Compare EVH & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVH | SOPH |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.1M | 462.3M |
| IPO Year | 2015 | 2021 |
| Metric | EVH | SOPH |
|---|---|---|
| Price | $4.22 | $7.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $5.75 | ★ $9.75 |
| AVG Volume (30 Days) | ★ 1.8M | 557.6K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,957,000.00 | N/A |
| Revenue This Year | $40.46 | $23.24 |
| Revenue Next Year | $25.06 | $24.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $3.83 |
| 52 Week High | $6.89 | $8.98 |
| Indicator | EVH | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 50.34 |
| Support Level | $3.52 | $4.58 |
| Resistance Level | $5.02 | $7.88 |
| Average True Range (ATR) | 0.29 | 0.44 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 14.56 | 71.47 |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.